Aaron Goldman

Publication Activity (10 Years)

Years Active: 2019-2021
Publications (10 Years): 5

Top Topics

Small Cell Lung Cancer

Top Venues

Science signaling

PLoS computational biology

Chemical reviews

This page only lists publications with an associated author ORCID identifier.

Publications

Michelle Przedborski, Munisha Smalley, Saravanan Thiyagarajan, Aaron Goldman, Mohammad Kohandel
Systems biology informed neural networks (SBINN) predict response and novel combinations for PD-1 checkpoint blockade. Communications biology 4 (1) (2021)
Tanmoy Saha, Jayanta Mondal, Sachin Khiste, Hrvoje Lusic, Zhang-Wei Hu, Ruparoshni Jayabalan, Kevin J Hodgetts, HaeLin Jang, Shiladitya Sengupta, Somin Eunice Lee, Younggeun Park, Luke P Lee, Aaron Goldman
Nanotherapeutic approaches to overcome distinct drug resistance barriers in models of breast cancer. Nanophotonics 10 (12) (2021)
Morgan Craig, Adrianne L Jenner, Bumseok Namgung, Luke P Lee, Aaron Goldman
Engineering in Medicine To Address the Challenge of Cancer Drug Resistance: From Micro- and Nanotechnologies to Computational and Mathematical Modeling. Chemical reviews 121 (6) (2020)
Aaron Goldman, Sachin Khiste, Elizaveta Freinkman, Andrew Dhawan, Biswanath Majumder, Jayanta Mondal, Anthony B Pinkerton, Elliot O Eton, Ragini Medhi, Vineethkrishna Chandrasekar, M Mamunur Rahman, Takaharu Ichimura, Kodaganur S Gopinath, Pradip Majumder, Mohammad Kohandel, Shiladitya Sengupta
Targeting tumor phenotypic plasticity and metabolic remodeling in adaptive cross-drug tolerance. Science signaling 12 (595) (2019)
Morgan Craig, Kamran Kaveh, Alec Woosley, Andrew S Brown, David Goldman, Elliot O Eton, Ravindra M Mehta, Andrew Dhawan, Kazuya Arai, M Mamunur Rahman, Sidi Chen, Martin A Nowak, Aaron Goldman
Cooperative adaptation to therapy (CAT) confers resistance in heterogeneous non-small cell lung cancer. PLoS computational biology 15 (8) (2019)